Aster Capital Management (Difc) LTD Corcept Therapeutics Inc Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 44 shares of CORT stock, worth $3,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44Holding current value
$3,199% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
392Shares Held
86.5MCall Options Held
1.13MPut Options Held
749K-
Black Rock Inc. New York, NY16.5MShares$1.2 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$736 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$589 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$451 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$278 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.79B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...